It is a great honor and privilege to be invited as a guest editor for this issue of the American Journal of Rhinology & Allergy (AJRA). As always, the editors in chief have demonstrated remarkable leadership and have done an outstanding job in selecting high-quality research manuscripts after a rigorous review process.
With the rapidly growing body of knowledge, it is becoming difficult for otolaryngologists to develop and sustain an updated decision-making process in patient management. The evidence-based medicine-oriented physicians integrate clinical expertise, patient values, and the best available evidence to provide high-quality, cost-effective care for their patients. Multiple concepts in the field of rhinology and allergy are being introduced that add to our understanding of disease processes. Several articles in this issue of the AJRA examine the evidence, quality, and innovation related to multiple topics covering the broad range of rhinologic and allergic diseases.
Chronic rhinitis affects around 60 million in the United States with an increasing prevalence. [1] [2] [3] Treatment has been traditionally in the form of medical management with oral and/or nasal antihistamine and corticosteroids as well as nasal turbinate reduction. In 1961, definitive surgical management of rhinitis in the form of vidian neurectomy was introduced; however, this technique has lost its popularity due to its complexity, side effects, and its transient effectiveness. 4, 5 Recently, the role of minimally invasive approach in the form of cryotherapy has been explored. In this issue, Kompelli et al. 6 performed a qualitative systematic review to assess the safety and efficacy of cryotherapy in the management of chronic rhinitis. Despite the promising results of symptom reduction in the 15 studies included, more studies with controlled populations and validated metrics are needed to make strong evidence-based recommendations.
Epistaxis in the elderly is quite distressing and may require hospitalization for control. Cost of managing epistaxis is primarily related to procedures performed and length of hospitalization. In the study by Zhou et al. 7 that queried the National Inpatient Sample from 2008 to 2013, no nasal packing was associated with significant increase in length of hospitalization and hospital charges compared to nasal packing (anterior or posterior). In addition, embolization was associated with increased hospital charges compared to ligation. Interestingly, the morbidity and mortality were not different in any of the comparison groups.
Teaching frontal sinus surgery and anatomy to residents is particularly challenging. In this issue, Chen et al. 8 reported their experience in the use of the modified frontal sinus master class (FSMS) simulation as an educational tool for locating the frontal sinus drainage pathway. The modified FSMS relied on a software that utilizes the 3-dimensional building block concept and was found to significantly improve the residents' anatomical knowledge of the frontal sinus drainage pathway.
Chronic rhinosinusitis (CRS) is a heterogenous disorder that is clinically divided into CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP). Compared to CRSsNP, CRSwNP is known to have a higher disease burden and tissue eosinophilia. It is unclear how immunosuppression affects the histopathology and severity of patients with CRS. Papagiannopoulos et al. 9 examined the histopathology and disease severity of CRS with immunosuppression (CRSi). CRSi patients exhibited histopathology and disease severity more like CRSsNP with trends toward increased neutrophilia and reduced fibrosis. This study provides initial insight into understanding CRSi which may have implications on disease management.
Currently, radiologic imaging in the form of computed tomography scan of the sinuses is the gold standard for assessing sinonasal inflammation. Oliver et al. 10 introduced the baseline exhaled nitric oxide as a potential point of care screening tool that assesses sinonasal opacification. In this study, baseline nitric oxide positively correlated with Lund-Mckay scores and modified sinonasal outcome test-26.
In this issue, Wu et al. 11 performed a web-based survey to compare the use of systemic steroids in pediatric patients with orbital complications from acute sinusitis among fellowship-trained members of American Society of Pediatric Otolaryngology and American Rhinologic Society. The practice patterns were found to be different between the 2 groups with fellowship-trained pediatric otolaryngologists significantly more likely (2.88 times) to prescribe corticosteroids for children than rhinologists. Further studies are still needed to provide evidence-based guidelines for the use of steroids in complicated acute sinusitis.
Indications for the use of transnasal endoscopic approach to sinonasal and skull base lesions have expanded over the past few decades. This is due to the accumulating experience of rhinologists and the development of specialized instruments. In this issue, Zhou et al. 12 reported on their experience in the use of the intranasal endoscopic prelacrimal recess approach for Krouse T3 stage inverted papilloma. The procedure was found to be safe with low recurrence (7.04%). Their observed rates of side effects were low at 7.04% for numbness of the upper lid and the ala of the nose and 5.63% for mild collapse of the ala of the nose. Also, Badran et al. 13 conducted a systematic review on the management of pediatric benign sinonasal osteogenic tumors. Purely endoscopic, combined assisted, or open approaches did not affect the rates of recurrence and postoperative complications.
In addition to the rhinologic concepts, this issue also includes 3 articles on new research in allergic diseases. Liu et al.
14 explored measuring the levels of IgE, IgA, and G4 in salivary gland secretions of allergic patients to house dust mites Dermatophagoides pteronyssinus (Dp). No correlation was found between allergic rhinitis (AR) symptoms and the levels of the salivary gland-specific antibodies (Dp-IgA, Dp-IgE, and Dp-IgG4) in patients undergoing subcutaneous immunotherapy (SCIT) to house dust mites. Compared to healthy controls, salivary Dp-IgG4 and Dp-IgA levels were significantly lower, and Dp-IgE levels were significantly higher in AR patients. SCIT resulted in sustained increases in Dp-IgG4 and Dp-IgA in the maintenance phase of immunotherapy. The specific antibodies in the salivary gland secretions may be used for diagnosis (Dp-IgE) or to objectively evaluate the response to treatment with immunotherapy (Dp-IgG4 and Dp-IgA).
Muluk et al.'s 15 review article highlighted the association between Staphylococcal aureus superantigens and AR, asthma, atopic dermatitis, and CRS. Patients with allergic asthma and rhinitis have serological evidence of IgE to superantigens produced by S. aureus. These superantigens potentially increase the risk of developing CRSwNP and may serve as a marker for disease severity. The role of S. aureus superantigens in allergic diseases still warrants further exploration. Finally, Keefe et al. 16 reported their experience in a retrospective study on the compliance of SCIT in an urban "safety-net" tertiary care center in Massachusetts. The study showed a high overall compliance to SCIT, as measured by adherence (percentage of injections administered/scheduled appointments), but lower in the Medicaid population.
The current issue of the AJRA covers the broad spectrum of rhinologic and allergic diseases. The editors should be commended in selecting high-quality articles that address controversial topics and add to our knowledge in the field. As readers, we can use the evidence presented in this issue to improve the quality of care that we provide to our patients and enhance academic knowledge.
